1. Bruton’s Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3
   Anselm Morell et al, 2020, Cancers CrossRef
2. AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition
   Xinyu Shao et al, 2021, Aging CrossRef
3. The acylfulvene alkylating agent, LP-184, retains nanomolar potency in non-small cell lung cancer carrying otherwise therapy-refractory mutations
   Aditya Kulkarni et al, 2021, Oncotarget CrossRef
4. Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks
   Sreeparna Banerjee, 2021, Cell Biology and Translational Medicine, Volume 14 CrossRef
5. The Role of AKR1B10 in Physiology and Pathophysiology
   Satoshi Endo et al, 2021, Metabolites CrossRef